184 related articles for article (PubMed ID: 29171692)
21. Structure-based design of novel pyrimido[4,5-c]pyridazine derivatives as dihydropteroate synthase inhibitors with increased affinity.
Zhao Y; Hammoudeh D; Yun MK; Qi J; White SW; Lee RE
ChemMedChem; 2012 May; 7(5):861-70. PubMed ID: 22416048
[TBL] [Abstract][Full Text] [Related]
22. A rapid assay for dihydropteroate synthase activity suitable for identification of inhibitors.
Fernley RT; Iliades P; Macreadie I
Anal Biochem; 2007 Jan; 360(2):227-34. PubMed ID: 17134675
[TBL] [Abstract][Full Text] [Related]
23. Biochemical and structural characterization of the putative dihydropteroate synthase ortholog Rv1207 of Mycobacterium tuberculosis.
Gengenbacher M; Xu T; Niyomrattanakit P; Spraggon G; Dick T
FEMS Microbiol Lett; 2008 Oct; 287(1):128-35. PubMed ID: 18680522
[TBL] [Abstract][Full Text] [Related]
24. Elucidation of sulfadoxine resistance with structural models of the bifunctional Plasmodium falciparum dihydropterin pyrophosphokinase-dihydropteroate synthase.
de Beer TA; Louw AI; Joubert F
Bioorg Med Chem; 2006 Jul; 14(13):4433-43. PubMed ID: 16517168
[TBL] [Abstract][Full Text] [Related]
25. Computational insights into factor affecting the potency of diaryl sulfone analogs as Escherichia coli dihydropteroate synthase inhibitors.
Das BK; Pv P; Chakraborty D
Comput Biol Chem; 2019 Feb; 78():37-52. PubMed ID: 30497019
[TBL] [Abstract][Full Text] [Related]
26. Exploring the chemical space around 8-mercaptoguanine as a route to new inhibitors of the folate biosynthesis enzyme HPPK.
Chhabra S; Barlow N; Dolezal O; Hattarki MK; Newman J; Peat TS; Graham B; Swarbrick JD
PLoS One; 2013; 8(4):e59535. PubMed ID: 23565155
[TBL] [Abstract][Full Text] [Related]
27. Probing the binding mechanism of mercaptoguanine derivatives as inhibitors of HPPK by docking and molecular dynamics simulations.
Marimuthu P; Singaravelu K; Namasivayam V
J Biomol Struct Dyn; 2017 Dec; 35(16):3507-3521. PubMed ID: 27844507
[TBL] [Abstract][Full Text] [Related]
28. Catalysis and sulfa drug resistance in dihydropteroate synthase.
Yun MK; Wu Y; Li Z; Zhao Y; Waddell MB; Ferreira AM; Lee RE; Bashford D; White SW
Science; 2012 Mar; 335(6072):1110-4. PubMed ID: 22383850
[TBL] [Abstract][Full Text] [Related]
29. Structural Basis for the Selective Binding of Inhibitors to 6-Hydroxymethyl-7,8-dihydropterin Pyrophosphokinase from Staphylococcus aureus and Escherichia coli.
Dennis ML; Pitcher NP; Lee MD; DeBono AJ; Wang ZC; Harjani JR; Rahmani R; Cleary B; Peat TS; Baell JB; Swarbrick JD
J Med Chem; 2016 Jun; 59(11):5248-63. PubMed ID: 27094768
[TBL] [Abstract][Full Text] [Related]
30. Inhibition studies of sulfonamide-containing folate analogs in yeast.
Patel O; Satchell J; Baell J; Fernley R; Coloe P; Macreadie I
Microb Drug Resist; 2003; 9(2):139-46. PubMed ID: 12820798
[TBL] [Abstract][Full Text] [Related]
31. Dihydropteroate synthase mutations in Pneumocystis jiroveci can affect sulfamethoxazole resistance in a Saccharomyces cerevisiae model.
Iliades P; Meshnick SR; Macreadie IG
Antimicrob Agents Chemother; 2004 Jul; 48(7):2617-23. PubMed ID: 15215118
[TBL] [Abstract][Full Text] [Related]
32. Examination of intrinsic sulfonamide resistance in Bacillus anthracis: a novel assay for dihydropteroate synthase.
Valderas MW; Andi B; Barrow WW; Cook PF
Biochim Biophys Acta; 2008 May; 1780(5):848-53. PubMed ID: 18342015
[TBL] [Abstract][Full Text] [Related]
33. Novel and potent inhibitors for dihydropteroate synthase of
Satuluri SH; Katari SK; Pasala C; Amineni U
J Recept Signal Transduct Res; 2020 Jun; 40(3):246-256. PubMed ID: 32098568
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of bi-substrate state mimics of dihydropteroate synthase as potential inhibitors and molecular probes.
Qi J; Virga KG; Das S; Zhao Y; Yun MK; White SW; Lee RE
Bioorg Med Chem; 2011 Feb; 19(3):1298-305. PubMed ID: 21216602
[TBL] [Abstract][Full Text] [Related]
35. Deciphering the competitive inhibition of dihydropteroate synthase by 8 marcaptoguanine analogs: enhanced potency in phenylsulfonyl fragments.
Das BK; Chakraborty D
J Biomol Struct Dyn; 2022; 40(23):13083-13102. PubMed ID: 34581241
[TBL] [Abstract][Full Text] [Related]
36. Bisubstrate analogue inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: synthesis and biochemical and crystallographic studies.
Shi G; Blaszczyk J; Ji X; Yan H
J Med Chem; 2001 Apr; 44(9):1364-71. PubMed ID: 11311059
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, antibacterial evaluation and molecular docking studies of some new quinoxaline derivatives targeting dihyropteroate synthase enzyme.
El-Attar MAZ; Elbayaa RY; Shaaban OG; Habib NS; Abdel Wahab AE; Abdelwahab IA; El-Hawash SAM
Bioorg Chem; 2018 Feb; 76():437-448. PubMed ID: 29275262
[TBL] [Abstract][Full Text] [Related]
38. Probing the roles of non-homologous insertions in the N-terminal domain of Plasmodium falciparum hydroxymethylpterin pyrophosphokinase-dihydropteroate synthase.
Rattanachuen W; Jönsson M; Swedberg G; Sirawaraporn W
Mol Biochem Parasitol; 2009 Dec; 168(2):135-42. PubMed ID: 19631695
[TBL] [Abstract][Full Text] [Related]
39. Bisubstrate analogue inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: New design with improved properties.
Shi G; Shaw G; Liang YH; Subburaman P; Li Y; Wu Y; Yan H; Ji X
Bioorg Med Chem; 2012 Jan; 20(1):47-57. PubMed ID: 22169600
[TBL] [Abstract][Full Text] [Related]
40. Identification and characterization of an allosteric inhibitory site on dihydropteroate synthase.
Hammoudeh DI; Daté M; Yun MK; Zhang W; Boyd VA; Viacava Follis A; Griffith E; Lee RE; Bashford D; White SW
ACS Chem Biol; 2014 Jun; 9(6):1294-302. PubMed ID: 24650357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
